epcoritamab
abbvie,genmab
['lymsm', 'dlbcl', 'epcoritamab', 'lymphoma']
#hematology first-line treatment (tx) with subcutaneous (sc) #epcoritamab (epco) + r-chop in patients (pts) with high-risk diffuse large b-cell #lymphoma (#dlbcl): phase 1/2 data update #lymsm #asco22 
Lymphoma Unit @Hospital_FJD & @UICOquironsalud. Board member @sehh_es & @SIOGorg. Councilor @EHA_Hematology Executive Board. Chairman SWG “Aging and Hematology”